While not specified for EOC, treatment with the DNMT inhibitor azacitidine showed tumor-inhibiting and anti-angiogenesis effect with a decreased amount of TECs and pericytes in other cancer types [212]. This evidence concerns the gene DNMT1 and neoplasm.